InflaRx NV (IFRX)

0.86 -0.03 (-2.87%) USD  |  NASDAQ  |  Feb 24, 13:22
More

InflaRx Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for IFRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
CDT Equity, Inc. --
LENZ Therapeutics, Inc. Upgrade
Liminatus Pharma, Inc. --
Oruka Therapeutics, Inc. Upgrade
Maze Therapeutics, Inc. Upgrade